Minh-Duy Phan

[Minh-Duy Phan @pmduy]

Will it be the next #antibiotic? A lasting treatment for #ChronicPain? A new way to stop #cancer in its tracks or a novel insight into the #genome?

Do your #PhD at IMB and join some of the world's best to see what you will discover.

🔍 Explore now: https://t.co/rrt3wUwCX3

[Schembri Lab @LabSchembri]

We combined TraDIS and metabolomics to identify new genes required for growth in human urine by multidrug-resistant Escherichia coli ST131 in a study led by @pmduy in collaboration with @KapplerUlrike and @MetaboHorst https://t.co/WsSKcALC6H

[Institute for Molecular Bioscience @IMBatUQ]

A new discovery reveals why some bacteria are life-threatening while others are harmless. @LabSchembri

🔗 Find out more: https://t.co/dFPPFfNGRE

[Schembri Lab @LabSchembri]

Really excited to present this work led by @nhunguyen2811 at @IMBatUQ in collaboration with @sumaira_hasnain Glen Ulett and Jana Vukovic.

[Schembri Lab @LabSchembri]

Very excited to share our work on NMEC led by @nhunguyen2811 (under review by eLife). We highlight that even with appropriate antibiotic treatment, causative NMEC that resides intestinally might not be eliminated and can cause relapse.

https://t.co/8nKXXRZ4FF

[Minh-Duy Phan @pmduy]

Looking forward to present this work at @GlobalUti - with contributions from @danmed @nhunguyen2811 @brandonmqsy @IgnatiusPang @NWenner

[UTI Global Alliance @GlobalUti]

(2/3) #PresenterSpotlight Meet @pmduy, a senior postdoctoral Research Fellow in the @LabSchembri at the University of Queensland 🇦🇺 . Their submission is the result of an incredible international collaboration with @jay_salsa 🇬🇧 and @jaitreeau 🇦🇺 .

[Michael @MichaelLee04]

Try it now: https://t.co/53TlgVGkAd
Read the blog post: https://t.co/MH8BhejHeB
(8/8)

[Schembri Lab @LabSchembri]

Excited to share the final version of our paper on UPEC/ExPEC Ucl fimbriae published in PLoS Pathogens. A great collaboration between our lab and @MulveyLab, @Kobe_Lab_, @ThomasVe7, @GlycoGriffith, @beatsonlab
https://t.co/DcFufiEh45

[Jai Tree @jaitreeau]

In parallel work, the @GrannemanSander lab investigated sRNAs important for pathogenesis and found sRNAs controlling cytolytic PSM toxins!

https://t.co/RjwnDtlQrf

[Jai Tree @jaitreeau]

Our work on the RNA interactome of Staph is out (twice!). Using RNase III-CLASH our groups uncovered RNA interactions controlling vancomycin tolerance (a last-line antibiotic) and production of cytolytic toxins.
https://t.co/RjwnDtlQrf
https://t.co/ZqSKF7GZEx

[Schembri Lab @LabSchembri]

The plasmid gene aac(6’)-Ib-cr confers 4x increase in MIC to cipro in strains already harbour resistant gyrA and parC mutations. This dual resistance combination shows strong association with emerging carbapenem resistant clones.
https://t.co/Zj8K9SQpw7

[Amy Jennison @AmyVJennison]

We are looking for genomics scientists for public health genomics including SARS-CoV-2 real time surveillance for Queensland https://t.co/XzwpvxxQ1m and https://t.co/Ya8Zy6kP7F

[Minh-Duy Phan @pmduy]

@luke_allsopp @EalingCouncil Congrats Luke! I vote for a fish and chips by the beach!

[Minh-Duy Phan @pmduy]

Third paper from his PhD, @SteveMicrobio is our star!

[Schembri Lab @LabSchembri]

Discovery of DtrJ as an IncC plasmid conjugative transfer component - DtrJ is essential for DNA transfer and forms a complex with coupling protein TraD. Great work @SteveMicrobio @Loolibear @pmduy @beatsonlab @padstamundo https://t.co/8MKE67cpQp

[Schembri Lab @LabSchembri]

Discovery of DtrJ as an IncC plasmid conjugative transfer component - DtrJ is essential for DNA transfer and forms a complex with coupling protein TraD. Great work @SteveMicrobio @Loolibear @pmduy @beatsonlab @padstamundo https://t.co/8MKE67cpQp

[UQ News @UQ_News]

Infectious diseases are in the firing line of #UQ researchers, thanks to significant new #NHMRC funding.

@UQscience is at the forefront of this discovery, landing a significant share of UQ's total $25 million @nhmrc Ideas Grants funding.

https://t.co/MDHLjvRqoQ #UQResearch

[Andrew Page @andrewjpage.bsky.social @andrewjpage]

In Norfolk in November (& 1st 3 days of Dec), 19% (131/681) of SARS-CoV-2 genomes were the new variant (B.1.1.7). There were none in October so this has expanded quite rapidly.

[Minh-Duy Phan @pmduy]

Proud to have a small contribution to this excellent work!

[David De Oliveira @DrDe_Oliveira]

How do you re-purpose a neurodegenerative disease drug to reverse #antimicrobialresistance in Gram-negative bacteria? Read our teams latest publication in @ScienceTM. @MarkvonI @camcdevitt @fordebm @mailaved @LabSchembri @davidantibiotic @UQ_SCMB
@UQ_News https://t.co/lrsHsViWCq

[Pedro Beltrao @pedrobeltrao]

In another effort by the QBI Coronavirus Research Group, we and many others have studied the commonalities of host targeted mechanisms of SARS-CoV-2, SARS-CoV-1 and MERS-CoV, identifying drug targets with potential pan-coronavirus activity #QCRGglobal https://t.co/jnSe0Tw76L

[Rhys White 🧬 @RhysTWhite]

Speakers for ASM-QLD #MiM_20 are announced! Our Simmons Trust speaker is @ProfPaulYoung w/ invited speaker @DrTotsika. Great #science & diversity across the #microbiology community. NOTE there's a 2.5hr session on Sat 31-OCT & 7-NOV. See https://t.co/JzTGweTV9T

Mem🆓 Non-mem $5